Concepedia

Author

Richard Simon

National Cancer InstituteORCID

Also Known As

B Etzold, Leonard D. Shultz, McShane, Lisa M., R M Simon, R Simon, R. M. Simon, R. SIMON, R. Simon, R.M. Simon, RICHARD M. SIMON

593

Publications

53.5K

Citations

108

H-Index

293

Concepts

All Affiliations

National Cancer InstituteNational Institutes of HealthInstitute of Mathematical Sciences
RS

About

Richard Simon is an author at National Cancer Institute specializing in medicine, biostatistics, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Health Sciences

30

42

11.1K

2

Engineering

28

41

7K

3

Business

2

2

92

4

Education

2

2

117

5

Arts

1

1

13

Richard Simon

×

256

Publications

46.4K

Citations

97

H-Index

YearCitations

Optimal two-stage designs for phase II clinical trials

Richard Simon

Controlled Clinical Trials

1989

3.6K

Flexible regression models with cubic splines

Sylvain Durrleman, Richard Simon

Statistics in Medicine

1989

2.6K

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

Stuart Pocock, Richard Simon

Biometrics

1975

2.3K

Bias in error estimation when using cross-validation for model selection

Sudhir Varma, Richard Simon

BMC Bioinformatics

2006

1.8K

Comparison of MR/Ultrasound Fusion–Guided Biopsy With Ultrasound-Guided Biopsy for the Diagnosis of Prostate Cancer

Mohummad Minhaj Siddiqui, Soroush Rais‐Bahrami, Barış Türkbey,

JAMA

2015

1.5K

Prediction error estimation: a comparison of resampling methods

Annette M. Molinaro, Richard Simon, Ruth M. Pfeiffer

Bioinformatics

2005

1.3K

Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma

Andreas Rosenwald, George W. Wright, Karen Leroy,

The Journal of Experimental Medicine

2003

1.1K

Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers

Richard Simon, Seungmok Paik, Daniel F. Hayes

JNCI Journal of the National Cancer Institute

2009

1K

Comparison of In Vitro Anticancer-Drug-Screening Data Generated With a Tetrazolium Assay Versus a Protein Assay Against a Diverse Panel of Human Tumor Cell Lines

Larry Rubinstein, Robert H. Shoemaker, Kenneth D. Paull,

JNCI Journal of the National Cancer Institute

1990

927

The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma

Andreas Rosenwald, George W. Wright, Adrian Wiestner,

Cancer Cell

2003

924

Page 1